Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02152943
Title Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
MD Anderson in Katy Houston Texas 77094 United States Details
MD Anderson League City Nassau Bay Texas 77058 United States Details
MD Anderson in Sugar Land Sugar Land Texas 77478 United States Details
MD Anderson in The Woodlands The Woodlands Texas 77384 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field